FREQUENCY AND CLINICAL EPIDEMIOLOGICAL DESCRIPTION OF MAIN BRONCHOPULMONARY DISEASES IN THE MILITARY

Mokhida A. Jakbarova, Mokhigul A. Juraeva — Tue, 18 Mar 2025 00:00:00 +0000

Studying the prevalence of major bronchopulmonary diseases is one of the important indicators determining the health of the population, including among the military. The data obtained as a result of a number of studies have different indicators, which are related to living and working conditions, the methodology of the data obtained, diagnostic methods and the availability of preventive measures. The purpose of our study; to study the frequency of detection and clinical epidemiological characteristics of major bronchopulmonary diseases in the military. In doing so, we set ourselves the task of studying community-acquired pneumonia, chronic nonspecific lung diseases (chronic bronchitis, chronic obstructive pulmonary disease, bronchial asthma) among the military. In order to obtain complete information about the main symptoms and course of the diseases, prospective studies were conducted in patients treated in 2023. For this, 273 servicemen from the Tashkent Central Military Clinical Hospital were recruited and divided into the following age groups: under 29 years old, 30-39 years old, 40-49 years old, and 50 and older. People aged 60 and 70 were not divided into a separate group due to the low number of participants in the study.

Of these, 33.7% (92) were relatively healthy servicemen with no pulmonary diseases, 33.7% (92) were diagnosed with community-acquired pneumonia, and 32.6% (89) with chronic nonspecific pulmonary diseases (CNPD).

BIOCHEMICAL FACTORS AFFECTING THE FREQUENCY OF SEIZURES IN EPILEPTIC PATIENTS AFTER COVID-19 INFECTION

Khanifa Khalimova , Nilufar Rashidova , Saykha Ilkhomova — Tue, 18 Mar 2025 00:00:00 +0000

The COVID-19 pandemic has significantly affected various health conditions, including epilepsy, with long-term implications. This study explores the biochemical factors influencing the frequency of seizures in epileptic patients following COVID-19 infection. Biochemical markers such as inflammation markers (CRP, IL-6), hypoxia and thrombosis markers (D-dimer), metabolic indicators (glucose, insulin, HbA1c), and electrolyte imbalances (Na+, K+, Ca2+, Mg2+) were assessed. The results show that COVID-19 infection increased seizure frequency, with heightened levels of inflammation, thrombosis, and metabolic disturbances contributing to this change. Understanding these biochemical factors can help develop targeted therapeutic strategies for managing seizures in epileptic patients post-COVID-19.

Central Asian Journal of Medicine

FREQUENCY AND CLINICAL EPIDEMIOLOGICAL DESCRIPTION OF MAIN BRONCHOPULMONARY DISEASES IN THE MILITARY

BIOCHEMICAL FACTORS AFFECTING THE FREQUENCY OF SEIZURES IN EPILEPTIC PATIENTS AFTER COVID-19 INFECTION